Optic-nerve gliomas, chiasmal gliomas and neurofibromatosis type 1

Current Opinion in Ophthalmology

Volumn 17, Issue 1, 2006, Pages 7-11

  Sylvester, Christin L ^a   Drohan, Lea Ann ^b   Sergott, Robert C ^c  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Neurofibromatosis type 1; Optic pathway gliomas

Indexed keywords

AUTOSOMAL DOMINANT INHERITANCE; BRAIN TUMOR; DISEASE COURSE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; NEUROFIBROMATOSIS; OPTIC CHIASM; OPTIC NERVE GLIOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; TREATMENT PLANNING; VISUAL SYSTEM;

HUMANS; NEUROFIBROMATOSIS 1; OPTIC CHIASM; OPTIC NERVE GLIOMA; OPTIC NERVE NEOPLASMS;

EID: 29844441330     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.icu.0000193070.32369.37     Document Type: Review

References (17)

1. Huson S. Clinical and genetic studies of von Recklinghausen neurofibromatosis. MD Thesis. Edinburgh: Edinburgh University, 1989.
2. In: Wright K, Spiegel P, editors. Pediatric Ophthalmology and Strabismus. New York: Springer-Verlag; 2003. pp. 766.
3. King A, Listernick R, Charrow J, et al. Optic pathway glioma in neurofibromatosis type 1 - The effect of presenting symptoms on outcome. Am J Med Genet 2003; 122:95-99. This large retrospective patient analysis provides conclusive evidence that high risk prognostic factors of tumors likely to develop into progressive OPG do not exist to date.
4. Listernick R, Frener RE, Piersall L, et al. Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology 2004; 63:1944-1946. This paper reports the possibility of a new timeline for the natural history of OPGs in NF1.
5. Czyzyk E, Jozwiak S, Roszkowski M, Schwartz R. Optic pathway gliomas in children with and without neurofibromatosis 1. J Child Neurol 2003; 18:471-478.
6. Balcer L, Liu G, Heller G, et al. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: Relation to tumor location by magnetic resonance imaging. Am J Ophthalmol 2001; 131:442-445.
7. Singhal S, Birch JM, Kerr B, et al. Neurofibromatosis type 1 and sporadic optic gliomas. Arch Dis Child 2002; 87:65-70. This paper discusses the concern for tumor progression after irradiation of OPG in NF-1 and also evokes a new concern for the development of secondary CNS tumors in these patients.
8. Thiagalingam S, Flaherty M, Billson F, Novin K. Neurofibromatosis type 1 and optic pathway gliomas: Follow up of 54 patients. Ophthalmology 2004; 111:568-577. This paper suggests a more varied natural history course for NF1 OPGs than previously documented and proposes new follow-up recommendations.
9. Gayre G, Scott I, Feuer W, et al. Long-term visual outcome in patients with anterior visual pathway gliomas. J Neuroophthalmol 2001; 21:1-7.
10. Listernick R, Louis D, Packer R, Gutmann D. Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 1997; 41:142-148.
11. Astrup J. Natural history and clinical management of optic pathway glioma. Br J Neurosurg 2003; 17:327-335.
12. Khafaga Y, Hassounah M, Kandil A, et al. Optic gliomas: a retrospective analysis of 50 cases. Int J Radiat Oncol Biol Phys 2003; 56:807-812.
13. Grill J, Laithier V, Rodriguez D, et al. When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre. Eur J Pediatr 2000; 159:692-696. This paper supports a delayed natural history course of NF1 OPG with appropriate follow up recommendation based on the findings.
14. Tow S, Chandela S, Miller N, Avellino A. Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr Neurol 2002; 28:262-270.
15. Combs S, Schulz-Ertner D, Moshos D, et al. Fractionated stereotactic radiotherapy of optic pathway gliomas: Tolerance and long-term outcome. Int J Radiat Oncol Biol Phys 2005; 62:814-819.
16. Friedman JM, Birsh P. An association between optic glioma and other tumors of the central nervous system in neurofibromatosis type 1. Neuropediatrics 1997; 28:131-132.
17. Rush JA, Young BR, Campbell RJ, et al. Optic glioma: long term follow-up of 85 histopathologically verified cases. Ophthalmology 1982; 89:1213-1219.